SYROS PHARMACEUTICALS INC (SYRS)
US87184Q2066 - Common Stock
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 23.49M 55.67% | 14.88M -36.65% | 9.936M -33.23% | 459K -95.38% | 5.1M 1,011.11% | 30.6M 500.00% | 1.7M -94.44% | 1.7M | 1.7M | 88.502M 5,106.00% | 5.1M -94.24% | |
| EBITDA YoY % growth | -96.4M -21.63% | -123.39M -28.00% | -124.247M -0.69% | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -99.42M -20.80% | -126.36M -27.10% | -126.499M -0.11% | -114.92M 9.15% | -94.69M 17.60% | -101.558M -7.25% | -101.864M -0.30% | -114.614M -12.52% | -133.824M -16.76% | -97.104M 27.44% | -130.764M -34.66% | |
| Operating Margin | -423.24% | -849.19% | -1,273.14% | -25,037.04% | -1,856.67% | -331.89% | -5,992.00% | -6,742.00% | -7,872.00% | -109.72% | -2,564.00% | |
| EPS YoY % growth | -13.80 24.18% | -12.78 7.39% | -5.76 54.93% | -1.58 72.55% | -2.10 -32.90% | -1.73 17.72% | -3.13 -81.12% | -3.42 -9.28% | -4.23 -23.55% | -2.75 34.86% | -2.38 13.70% |
All data in USD
| Q4 / 24 | Q1 / 25 | Q2 / 25 | Q3 / 25 | Q4 / 25 | |
|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.69 68.42% | -0.55 -450.80% | -0.49 17.02% | -0.45 -180.50% | -0.43 37.04% |
| Revenue Q2Q % growth | 459K 18.60% | -100.00% | |||
| EBITDA Q2Q % growth | N/A | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -27.88M -3.24% | -22.185M 28.25% | -19.635M 28.38% | -18.411M 29.68% | -18.666M 33.05% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2024 Q2Q % growth | -0.16 88.81% | -0.73 | 0.57 | 78.21% |
| Q2 2024 Q2Q % growth | -0.59 54.62% | -0.78 | 0.19 | 24.66% |
| Q1 2024 Q2Q % growth | -0.10 88.24% | -0.89 | 0.79 | 88.72% |
| Q4 2023 Q2Q % growth | -2.18 -1,182.35% | -1.17 | -1.01 | -86.73% |
| Q3 2023 Q2Q % growth | -1.43 55.45% | -1.16 | -0.27 | -22.83% |
| Q2 2023 Q2Q % growth | -1.30 75.93% | -1.15 | -0.15 | -12.95% |
| Q1 2023 Q2Q % growth | -0.85 78.75% | -1.11 | 0.26 | 23.58% |
| Q4 2022 Q2Q % growth | -0.17 95.53% | -1.38 | 1.21 | 87.67% |
| Q3 2022 Q2Q % growth | -3.21 21.71% | -4.09 | 0.88 | 21.52% |
| Q2 2022 Q2Q % growth | -5.40 -50.00% | -4.16 | -1.24 | -29.76% |
| Q1 2022 Q2Q % growth | -4.00 -73.91% | -4.79 | 0.79 | 16.56% |
| Q4 2021 Q2Q % growth | -3.80 38.71% | -4.75 | 0.95 | 20.00% |
| Q3 2021 Q2Q % growth | -4.10 4.65% | -4.49 | 0.39 | 8.65% |
| Q2 2021 Q2Q % growth | -3.60 5.26% | -3.80 | 0.20 | 5.22% |
| Q1 2021 Q2Q % growth | -2.30 41.03% | -4.74 | 2.44 | 51.48% |
| Q4 2020 Q2Q % growth | -6.20 -34.78% | -5.09 | -1.11 | -21.75% |
| Q3 2020 Q2Q % growth | -4.30 8.51% | -3.92 | -0.38 | -9.67% |
| Q2 2020 Q2Q % growth | -3.80 19.15% | -4.10 | 0.30 | 7.33% |
| Q1 2020 Q2Q % growth | -3.90 20.41% | -4.42 | 0.52 | 11.85% |
| Q4 2019 Q2Q % growth | -4.60 | -4.78 | 0.18 | 3.70% |
| Q3 2019 Q2Q % growth | -4.70 | -4.88 | 0.18 | 3.77% |
| Q2 2019 Q2Q % growth | -4.70 | -4.24 | -0.46 | -10.88% |
| Q1 2019 Q2Q % growth | -4.90 | -5.80 | 0.90 | 15.49% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2024 Q2Q % growth | -100.00% | 459K | -459K | -100.00% |
| Q2 2024 Q2Q % growth | -100.00% | 469.2K | -469.2K | -100.00% |
| Q1 2024 Q2Q % growth | -100.00% | 734.4K | -734.4K | -100.00% |
| Q4 2023 Q2Q % growth | 387K 151.60% | 2.04M | -1.653M | -81.03% |
| Q3 2023 Q2Q % growth | 3.762M -3.29% | 4.019M | -257K | -6.39% |
| Q2 2023 Q2Q % growth | 2.833M -54.89% | 3.57M | -737K | -20.64% |
| Q1 2023 Q2Q % growth | 2.954M -46.00% | 3.325M | -371K | -11.16% |
| Q4 2022 Q2Q % growth | -750K -109.62% | 4.06M | -4.81M | -118.47% |
| Q3 2022 Q2Q % growth | 3.89M -31.75% | 5.284M | -1.394M | -26.38% |
| Q2 2022 Q2Q % growth | 6.28M 21.71% | 4.769M | 1.511M | 31.68% |
| Q1 2022 Q2Q % growth | 5.47M 13.25% | 5.022M | 448K | 8.92% |
| Q4 2021 Q2Q % growth | 7.8M 36.84% | 4.896M | 2.904M | 59.31% |
| Q3 2021 Q2Q % growth | 5.7M 48.83% | 4.579M | 1.121M | 24.48% |
| Q2 2021 Q2Q % growth | 5.16M 61.76% | 4.217M | 943K | 22.36% |
| Q1 2021 Q2Q % growth | 4.83M 102.94% | 2.723M | 2.107M | 77.38% |
| Q4 2020 Q2Q % growth | 5.7M 1,017.65% | 2.75M | 2.95M | 107.27% |
| Q3 2020 Q2Q % growth | 3.83M 583.93% | 2.595M | 1.235M | 47.59% |
| Q2 2020 Q2Q % growth | 3.19M 593.48% | 1.94M | 1.25M | 64.43% |
| Q1 2020 Q2Q % growth | 2.38M 428.89% | 1.655M | 725K | 43.81% |
| Q4 2019 Q2Q % growth | 510K | 705.116K | -195.116K | -27.67% |
| Q3 2019 Q2Q % growth | 560K | 449.82K | 110.18K | 24.49% |
| Q2 2019 Q2Q % growth | 460K | 438.896K | 21.104K | 4.81% |
| Q1 2019 Q2Q % growth | 450K | 437.141K | 12.859K | 2.94% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 0% | 15.24% | 0% | 28.17% |
| Revenue | 0% | -2.17% | 0% | -48.57% |